CN Stock MarketDetailed Quotes

300391 Changjiang Pharmaceutical Group

Watchlist
  • 4.90
  • -0.04-0.81%
Market Closed Oct 15 15:00 CST
1.72BMarket Cap-2338P/E (TTM)

Changjiang Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
-21.35%10.06M
-32.30%8.55M
-13.00%15.2M
47.42%13.83M
-91.87%12.79M
-93.73%12.63M
-83.77%17.47M
-91.93%9.38M
38.98%157.26M
142.49%201.3M
Notes receivable and accounts receivable
24.41%1.52B
13.49%1.6B
14.72%1.64B
6.87%1.57B
-10.97%1.22B
-1.54%1.41B
3.32%1.43B
23.19%1.47B
12.45%1.37B
15.60%1.44B
-Notes receivable
----
----
--100K
----
----
----
----
-96.26%80K
--30.69M
-66.25%1.84M
-Accounts receivable
24.41%1.52B
13.49%1.6B
14.71%1.64B
6.88%1.57B
-8.93%1.22B
-1.41%1.41B
3.70%1.43B
23.40%1.47B
9.93%1.34B
15.96%1.43B
Other receivables (including interest and dividends)
32.28%73.22M
550.29%259.18M
676.28%243.94M
47.00%71.09M
30.61%55.35M
-7.12%39.86M
-40.39%31.42M
-80.96%48.36M
-73.40%42.38M
-72.49%42.91M
-Other receivable
32.28%73.22M
----
676.28%243.94M
----
30.61%55.35M
----
-40.39%31.42M
----
-73.40%42.38M
----
Contractual assets
-95.38%845.31K
-62.15%6.92M
-62.15%6.92M
39.73%25.59M
-0.18%18.28M
71.50%18.28M
71.50%18.28M
-89.95%18.31M
-91.97%18.31M
-95.07%10.66M
Advance payment
-68.48%126.37M
-38.62%145.42M
-6.10%120.76M
104.65%176.42M
10.70%400.97M
-8.80%236.93M
3.82%128.6M
-25.61%86.21M
104.07%362.2M
-8.08%259.78M
Inventories
-60.41%54.15M
-24.98%53.7M
-12.80%51.86M
-52.58%56.91M
-1.34%136.77M
-54.99%71.59M
-69.55%59.47M
-39.21%120.02M
-47.51%138.63M
-18.47%159.07M
Receivable financing
171.43%95K
----
32.28%238.11K
359.40%3.57M
-99.93%35K
-99.19%827.08K
-99.86%180K
-99.44%776.19K
-48.61%50.69M
35.36%102.6M
Other current assets
-28.36%50.41M
-13.53%43.38M
-11.88%50.45M
-15.03%45.75M
38.87%70.36M
25.97%50.16M
1.42%57.25M
78.24%53.83M
78.10%50.67M
1,059.43%39.82M
Total current assets
-4.23%1.84B
15.05%2.12B
22.22%2.13B
8.70%1.97B
-12.59%1.92B
-18.12%1.84B
-15.41%1.74B
-18.83%1.81B
-4.24%2.19B
-0.10%2.25B
Non Current assets
Fixed assets
-11.54%748.72M
----
-13.44%763.86M
----
-21.41%846.42M
----
-20.34%882.47M
----
99.06%1.08B
----
Constru in process
0.54%189.25M
----
3.87%184.82M
----
7.25%188.23M
----
4.47%177.94M
----
-71.92%175.5M
----
Productive biological assets
----
----
-7.47%1.95M
-6.93%1.99M
-6.53%2.03M
-5.89%2.07M
-5.58%2.11M
-11.26%2.14M
-10.25%2.17M
-3.88%2.2M
Intangible assets
-2.70%97.83M
139.39%98.5M
137.60%99.18M
135.27%99.86M
78.46%100.54M
-32.28%41.15M
-33.39%41.74M
-33.70%42.45M
-14.51%56.34M
-10.65%60.76M
Goodwill
-66.32%208.63M
-65.05%236.07M
-65.05%236.07M
-11.72%619.51M
-11.72%619.51M
-3.75%675.43M
-3.75%675.43M
0.00%701.73M
0.00%701.73M
0.00%701.73M
Long deferred expense
----
----
----
----
-98.46%189.46K
-97.86%270.86K
-97.30%360.29K
-96.76%441.69K
-11.20%12.27M
-11.21%12.65M
Deferred tax assets
-64.04%16.47M
-59.52%16.47M
-58.63%16.47M
-52.04%17.56M
40.14%45.79M
-39.47%40.68M
-39.89%39.8M
-39.71%36.61M
-43.36%32.67M
27.70%67.2M
Usufruct assets
-38.24%6.45M
-32.33%8.78M
-23.57%11.77M
-59.26%7.37M
-51.14%10.44M
-45.09%12.98M
-41.14%15.39M
--18.09M
--21.38M
--23.64M
Other non current assets
86.07%5.01M
-51.96%813.5K
78.51%3.02M
-63.43%2.69M
-63.43%2.69M
-23.23%1.69M
-66.66%1.69M
-74.03%7.36M
-63.97%7.36M
-99.58%2.21M
Total non current assets
-29.93%1.27B
-28.16%1.31B
-28.30%1.32B
-4.65%1.78B
-12.97%1.82B
-14.08%1.82B
-14.78%1.84B
-9.14%1.86B
2.88%2.09B
-15.57%2.12B
Total assets
-16.74%3.11B
-6.44%3.43B
-3.71%3.45B
1.93%3.74B
-12.78%3.73B
-16.16%3.67B
-15.09%3.58B
-14.19%3.67B
-0.90%4.28B
-8.26%4.38B
Liabilities
Current liabilities
Short term loan
-56.65%219.72M
-59.25%214.98M
-61.91%205.12M
-13.95%475.4M
-23.05%506.91M
-15.66%527.57M
8.71%538.5M
21.60%552.46M
33.58%658.73M
12.25%625.53M
Notes payable and accounts payable
11.96%326.97M
45.02%361.12M
79.66%358.51M
21.40%302.68M
-44.86%292.05M
-57.75%249.02M
-68.96%199.55M
-54.95%249.32M
-6.90%529.63M
7.16%589.35M
-Notes payable
-96.46%1.49M
-57.76%2.8M
493.26%17.46M
255.38%19.26M
-64.05%42.21M
-94.82%6.62M
-97.23%2.94M
-95.27%5.42M
25.15%117.4M
65.62%127.89M
-Accounts payable
30.27%325.48M
47.82%358.33M
73.47%341.04M
16.20%283.42M
-39.39%249.84M
-47.47%242.4M
-63.35%196.61M
-44.43%243.9M
-13.23%412.22M
-2.39%461.46M
Contract liabilities
-47.54%13.74M
-31.47%13.57M
17.08%16.95M
80.11%34.02M
23.24%26.19M
42.41%19.81M
9.09%14.48M
-12.69%18.89M
35.00%21.25M
-61.18%13.91M
Salaries payable
13.17%26.6M
-0.76%22.11M
-10.86%18.52M
48.27%25.96M
9.90%23.5M
9.28%22.28M
-22.67%20.78M
-8.49%17.51M
-1.72%21.38M
7.30%20.39M
Taxs payable
-5.88%124.96M
-5.95%124.88M
-3.59%127.46M
5.44%135.99M
2.10%132.77M
1.87%132.78M
6.26%132.2M
-8.98%128.98M
0.09%130.04M
21.10%130.35M
Other payable (including interest and dividends)
48.87%961.98M
71.94%1.12B
84.00%1.04B
79.11%742.57M
-18.12%646.19M
-13.28%650.13M
-26.49%567.45M
-56.25%414.59M
-19.28%789.22M
-43.88%749.66M
-Interest payable
--23.89M
--28.74M
--20.44M
----
----
----
----
----
----
----
-Other payable
45.17%938.09M
----
80.40%1.02B
----
-18.12%646.19M
----
-26.49%567.45M
----
-19.25%789.22M
----
Non current liabilities due within one year
57.79%106.96M
162.73%106.38M
53.21%108.03M
68.34%60.18M
118.36%67.78M
29.11%40.49M
124.96%70.51M
--35.75M
--31.04M
--31.36M
Other current liabilities
-82.20%538.08K
-71.55%553.15K
8.66%1.72M
239.87%4.46M
-62.33%3.02M
15.70%1.94M
-58.88%1.59M
-46.63%1.31M
333.39%8.03M
22.34%1.68M
Total current liabilities
4.89%1.78B
19.31%1.96B
21.71%1.88B
25.55%1.78B
-22.42%1.7B
-23.97%1.64B
-26.77%1.55B
-33.71%1.42B
-0.89%2.19B
-17.06%2.16B
Current liabilities
Long term loan
62.19%510.9M
47.17%504.48M
54.76%518.89M
-13.05%317.39M
-21.25%315M
-6.88%342.79M
7.97%335.29M
8.96%365M
19.40%400M
8.27%368.12M
Long term account payable
----
----
----
----
-99.65%4.27K
----
-99.55%538.33K
----
-98.95%1.23M
----
Estimate liabilities
174.26%11.04M
-83.19%676.45K
-83.19%676.45K
--29.38M
-68.55%4.03M
-69.70%4.03M
-65.28%4.03M
----
1.48%12.8M
4.60%13.29M
Deferred tax liabilities
5.66%7.1M
3.00%7.1M
0.00%7.1M
-11.66%6.55M
-12.68%6.72M
-15.77%6.9M
-18.42%7.1M
-19.79%7.42M
-21.36%7.7M
-20.99%8.19M
Long term deferred income
-3.17%15.08M
-3.67%15.16M
-4.15%15.24M
-4.11%15.41M
-31.23%15.57M
-32.10%15.74M
-32.94%15.9M
-33.84%16.07M
-8.97%22.64M
-8.94%23.18M
Lease liabilities
6.84%5.96M
-69.95%6.25M
-8.68%5.45M
-73.60%5.56M
-74.09%5.58M
-2.46%20.79M
-71.75%5.97M
--21.04M
--21.52M
--21.32M
Other non current liabilities
723.87%650.31K
638.09%650.31K
723.87%650.31K
--78.93K
--78.93K
--88.11K
--78.93K
----
----
----
Total non current liabilities
58.72%550.73M
36.84%534.32M
48.55%548.01M
-29.10%374.36M
-25.52%346.98M
-29.47%390.48M
-25.51%368.92M
6.02%527.98M
-6.80%465.89M
-8.66%553.64M
Total liabilities
14.02%2.33B
22.67%2.5B
26.88%2.43B
10.73%2.16B
-22.97%2.05B
-25.09%2.03B
-26.53%1.91B
-26.21%1.95B
-1.98%2.66B
-15.48%2.72B
Shareholders equity
Paid-in capital
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
0.00%350.34M
Capital reserve funds
0.01%788.17M
0.01%788.17M
0.01%788.17M
-0.25%788.07M
-0.25%788.07M
-0.25%788.07M
-0.25%788.07M
0.00%790.05M
0.00%790.05M
0.00%790.05M
Surplus reserve funds
0.00%18.36M
0.00%18.36M
0.00%18.36M
0.00%18.36M
0.00%18.36M
-5.60%18.36M
0.00%18.36M
0.00%18.36M
0.00%18.36M
5.93%19.45M
Retained profit
-193.00%-1.11B
-166.26%-1.01B
-170.08%-961.75M
-54.54%-471.94M
-1.93%-380.31M
-18.32%-379.05M
-6.99%-356.09M
-7.07%-305.39M
-25.23%-373.09M
0.66%-320.37M
Other composite income
----
----
----
----
----
----
----
----
-5.01%-143.88K
882.32%918.75K
Specific reserves
----
----
----
----
----
----
----
----
-42.51%555.95K
50.97%348.97K
Shareholders equity without minority interests
-94.52%42.55M
-81.02%147.62M
-75.63%195.12M
-19.75%684.82M
-1.22%776.46M
-7.49%777.71M
-3.10%800.67M
-2.38%853.35M
-8.77%786.06M
0.52%840.73M
Minority interests
-19.50%733.07M
-7.89%788.59M
-4.83%822.2M
3.49%902.24M
8.68%910.59M
4.58%856.09M
10.34%863.95M
13.71%871.79M
12.11%837.86M
13.75%818.6M
Total shareholder equity
-54.03%775.62M
-42.70%936.2M
-38.89%1.02B
-8.00%1.59B
3.89%1.69B
-1.54%1.63B
3.44%1.66B
5.14%1.73B
0.93%1.62B
6.64%1.66B
Total liabilityies and equity
-16.74%3.11B
-6.44%3.43B
-3.71%3.45B
1.93%3.74B
-12.78%3.73B
-16.16%3.67B
-15.09%3.58B
-14.19%3.67B
-0.90%4.28B
-8.26%4.38B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
--
--
--
--
China Audit Asia Pacific Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds -21.35%10.06M-32.30%8.55M-13.00%15.2M47.42%13.83M-91.87%12.79M-93.73%12.63M-83.77%17.47M-91.93%9.38M38.98%157.26M142.49%201.3M
Notes receivable and accounts receivable 24.41%1.52B13.49%1.6B14.72%1.64B6.87%1.57B-10.97%1.22B-1.54%1.41B3.32%1.43B23.19%1.47B12.45%1.37B15.60%1.44B
-Notes receivable ----------100K-----------------96.26%80K--30.69M-66.25%1.84M
-Accounts receivable 24.41%1.52B13.49%1.6B14.71%1.64B6.88%1.57B-8.93%1.22B-1.41%1.41B3.70%1.43B23.40%1.47B9.93%1.34B15.96%1.43B
Other receivables (including interest and dividends) 32.28%73.22M550.29%259.18M676.28%243.94M47.00%71.09M30.61%55.35M-7.12%39.86M-40.39%31.42M-80.96%48.36M-73.40%42.38M-72.49%42.91M
-Other receivable 32.28%73.22M----676.28%243.94M----30.61%55.35M-----40.39%31.42M-----73.40%42.38M----
Contractual assets -95.38%845.31K-62.15%6.92M-62.15%6.92M39.73%25.59M-0.18%18.28M71.50%18.28M71.50%18.28M-89.95%18.31M-91.97%18.31M-95.07%10.66M
Advance payment -68.48%126.37M-38.62%145.42M-6.10%120.76M104.65%176.42M10.70%400.97M-8.80%236.93M3.82%128.6M-25.61%86.21M104.07%362.2M-8.08%259.78M
Inventories -60.41%54.15M-24.98%53.7M-12.80%51.86M-52.58%56.91M-1.34%136.77M-54.99%71.59M-69.55%59.47M-39.21%120.02M-47.51%138.63M-18.47%159.07M
Receivable financing 171.43%95K----32.28%238.11K359.40%3.57M-99.93%35K-99.19%827.08K-99.86%180K-99.44%776.19K-48.61%50.69M35.36%102.6M
Other current assets -28.36%50.41M-13.53%43.38M-11.88%50.45M-15.03%45.75M38.87%70.36M25.97%50.16M1.42%57.25M78.24%53.83M78.10%50.67M1,059.43%39.82M
Total current assets -4.23%1.84B15.05%2.12B22.22%2.13B8.70%1.97B-12.59%1.92B-18.12%1.84B-15.41%1.74B-18.83%1.81B-4.24%2.19B-0.10%2.25B
Non Current assets
Fixed assets -11.54%748.72M-----13.44%763.86M-----21.41%846.42M-----20.34%882.47M----99.06%1.08B----
Constru in process 0.54%189.25M----3.87%184.82M----7.25%188.23M----4.47%177.94M-----71.92%175.5M----
Productive biological assets ---------7.47%1.95M-6.93%1.99M-6.53%2.03M-5.89%2.07M-5.58%2.11M-11.26%2.14M-10.25%2.17M-3.88%2.2M
Intangible assets -2.70%97.83M139.39%98.5M137.60%99.18M135.27%99.86M78.46%100.54M-32.28%41.15M-33.39%41.74M-33.70%42.45M-14.51%56.34M-10.65%60.76M
Goodwill -66.32%208.63M-65.05%236.07M-65.05%236.07M-11.72%619.51M-11.72%619.51M-3.75%675.43M-3.75%675.43M0.00%701.73M0.00%701.73M0.00%701.73M
Long deferred expense -----------------98.46%189.46K-97.86%270.86K-97.30%360.29K-96.76%441.69K-11.20%12.27M-11.21%12.65M
Deferred tax assets -64.04%16.47M-59.52%16.47M-58.63%16.47M-52.04%17.56M40.14%45.79M-39.47%40.68M-39.89%39.8M-39.71%36.61M-43.36%32.67M27.70%67.2M
Usufruct assets -38.24%6.45M-32.33%8.78M-23.57%11.77M-59.26%7.37M-51.14%10.44M-45.09%12.98M-41.14%15.39M--18.09M--21.38M--23.64M
Other non current assets 86.07%5.01M-51.96%813.5K78.51%3.02M-63.43%2.69M-63.43%2.69M-23.23%1.69M-66.66%1.69M-74.03%7.36M-63.97%7.36M-99.58%2.21M
Total non current assets -29.93%1.27B-28.16%1.31B-28.30%1.32B-4.65%1.78B-12.97%1.82B-14.08%1.82B-14.78%1.84B-9.14%1.86B2.88%2.09B-15.57%2.12B
Total assets -16.74%3.11B-6.44%3.43B-3.71%3.45B1.93%3.74B-12.78%3.73B-16.16%3.67B-15.09%3.58B-14.19%3.67B-0.90%4.28B-8.26%4.38B
Liabilities
Current liabilities
Short term loan -56.65%219.72M-59.25%214.98M-61.91%205.12M-13.95%475.4M-23.05%506.91M-15.66%527.57M8.71%538.5M21.60%552.46M33.58%658.73M12.25%625.53M
Notes payable and accounts payable 11.96%326.97M45.02%361.12M79.66%358.51M21.40%302.68M-44.86%292.05M-57.75%249.02M-68.96%199.55M-54.95%249.32M-6.90%529.63M7.16%589.35M
-Notes payable -96.46%1.49M-57.76%2.8M493.26%17.46M255.38%19.26M-64.05%42.21M-94.82%6.62M-97.23%2.94M-95.27%5.42M25.15%117.4M65.62%127.89M
-Accounts payable 30.27%325.48M47.82%358.33M73.47%341.04M16.20%283.42M-39.39%249.84M-47.47%242.4M-63.35%196.61M-44.43%243.9M-13.23%412.22M-2.39%461.46M
Contract liabilities -47.54%13.74M-31.47%13.57M17.08%16.95M80.11%34.02M23.24%26.19M42.41%19.81M9.09%14.48M-12.69%18.89M35.00%21.25M-61.18%13.91M
Salaries payable 13.17%26.6M-0.76%22.11M-10.86%18.52M48.27%25.96M9.90%23.5M9.28%22.28M-22.67%20.78M-8.49%17.51M-1.72%21.38M7.30%20.39M
Taxs payable -5.88%124.96M-5.95%124.88M-3.59%127.46M5.44%135.99M2.10%132.77M1.87%132.78M6.26%132.2M-8.98%128.98M0.09%130.04M21.10%130.35M
Other payable (including interest and dividends) 48.87%961.98M71.94%1.12B84.00%1.04B79.11%742.57M-18.12%646.19M-13.28%650.13M-26.49%567.45M-56.25%414.59M-19.28%789.22M-43.88%749.66M
-Interest payable --23.89M--28.74M--20.44M----------------------------
-Other payable 45.17%938.09M----80.40%1.02B-----18.12%646.19M-----26.49%567.45M-----19.25%789.22M----
Non current liabilities due within one year 57.79%106.96M162.73%106.38M53.21%108.03M68.34%60.18M118.36%67.78M29.11%40.49M124.96%70.51M--35.75M--31.04M--31.36M
Other current liabilities -82.20%538.08K-71.55%553.15K8.66%1.72M239.87%4.46M-62.33%3.02M15.70%1.94M-58.88%1.59M-46.63%1.31M333.39%8.03M22.34%1.68M
Total current liabilities 4.89%1.78B19.31%1.96B21.71%1.88B25.55%1.78B-22.42%1.7B-23.97%1.64B-26.77%1.55B-33.71%1.42B-0.89%2.19B-17.06%2.16B
Current liabilities
Long term loan 62.19%510.9M47.17%504.48M54.76%518.89M-13.05%317.39M-21.25%315M-6.88%342.79M7.97%335.29M8.96%365M19.40%400M8.27%368.12M
Long term account payable -----------------99.65%4.27K-----99.55%538.33K-----98.95%1.23M----
Estimate liabilities 174.26%11.04M-83.19%676.45K-83.19%676.45K--29.38M-68.55%4.03M-69.70%4.03M-65.28%4.03M----1.48%12.8M4.60%13.29M
Deferred tax liabilities 5.66%7.1M3.00%7.1M0.00%7.1M-11.66%6.55M-12.68%6.72M-15.77%6.9M-18.42%7.1M-19.79%7.42M-21.36%7.7M-20.99%8.19M
Long term deferred income -3.17%15.08M-3.67%15.16M-4.15%15.24M-4.11%15.41M-31.23%15.57M-32.10%15.74M-32.94%15.9M-33.84%16.07M-8.97%22.64M-8.94%23.18M
Lease liabilities 6.84%5.96M-69.95%6.25M-8.68%5.45M-73.60%5.56M-74.09%5.58M-2.46%20.79M-71.75%5.97M--21.04M--21.52M--21.32M
Other non current liabilities 723.87%650.31K638.09%650.31K723.87%650.31K--78.93K--78.93K--88.11K--78.93K------------
Total non current liabilities 58.72%550.73M36.84%534.32M48.55%548.01M-29.10%374.36M-25.52%346.98M-29.47%390.48M-25.51%368.92M6.02%527.98M-6.80%465.89M-8.66%553.64M
Total liabilities 14.02%2.33B22.67%2.5B26.88%2.43B10.73%2.16B-22.97%2.05B-25.09%2.03B-26.53%1.91B-26.21%1.95B-1.98%2.66B-15.48%2.72B
Shareholders equity
Paid-in capital 0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M0.00%350.34M
Capital reserve funds 0.01%788.17M0.01%788.17M0.01%788.17M-0.25%788.07M-0.25%788.07M-0.25%788.07M-0.25%788.07M0.00%790.05M0.00%790.05M0.00%790.05M
Surplus reserve funds 0.00%18.36M0.00%18.36M0.00%18.36M0.00%18.36M0.00%18.36M-5.60%18.36M0.00%18.36M0.00%18.36M0.00%18.36M5.93%19.45M
Retained profit -193.00%-1.11B-166.26%-1.01B-170.08%-961.75M-54.54%-471.94M-1.93%-380.31M-18.32%-379.05M-6.99%-356.09M-7.07%-305.39M-25.23%-373.09M0.66%-320.37M
Other composite income ---------------------------------5.01%-143.88K882.32%918.75K
Specific reserves ---------------------------------42.51%555.95K50.97%348.97K
Shareholders equity without minority interests -94.52%42.55M-81.02%147.62M-75.63%195.12M-19.75%684.82M-1.22%776.46M-7.49%777.71M-3.10%800.67M-2.38%853.35M-8.77%786.06M0.52%840.73M
Minority interests -19.50%733.07M-7.89%788.59M-4.83%822.2M3.49%902.24M8.68%910.59M4.58%856.09M10.34%863.95M13.71%871.79M12.11%837.86M13.75%818.6M
Total shareholder equity -54.03%775.62M-42.70%936.2M-38.89%1.02B-8.00%1.59B3.89%1.69B-1.54%1.63B3.44%1.66B5.14%1.73B0.93%1.62B6.64%1.66B
Total liabilityies and equity -16.74%3.11B-6.44%3.43B-3.71%3.45B1.93%3.74B-12.78%3.73B-16.16%3.67B-15.09%3.58B-14.19%3.67B-0.90%4.28B-8.26%4.38B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------------Unqualified opinion------
Auditor ------------China Audit Asia Pacific Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data